SEC Filing Update: #CLRB Cellectar Biosciences, Inc. : $2.50

Sector: Healthcare | YTD: 🔽 -27.95% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has Newly bought 798,382 #CLRB shares Ownership: 9.99% * Estimated Investment Value: $2.04M https://www.thinksabio.com/reports/isr/CLRB 📌 Institutional activity in the last 30 days for #CLRB: • EMPERY ASSET MANAGEMENT, LP – Newly bought 864,090 shares (04-AUG-2026) • BLEICHROEDER LP – Increased holdings by 519,621 shares (13-AUG-2026)